跳至主要内容
临床试验/CTRI/2019/05/019197
CTRI/2019/05/019197已完成3 期

Phase III, multicentre, randomized, double-blind, placebo-controlled study to evaluate efficacy of probiotic supplementation for prevention of neonatal sepsis in 0-2 months old low birth weight infants in India

Indian Council of Medical Research Hqrs0 个研究点目标入组 6,144 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
6,144

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Birth weight: =1500 g to =2500 g
  • 2. Age of the new-born Day 3-7 on recruitment i.e. not later than 7th day
  • 3. Stable clinical condition as assessed by physician and accepting feeds orally (where stable is defined as, does not require intravenous fluids and vasopressor medication to maintain circulation and accepts oral feeding or breastfeeding).
  • 4. The mother (with the new-born) is planning to stay in study area for a period of at least two months

排除标准

  • 1. New born with extreme prematurity i.e. = 34 weeks
  • 2. New born with illness requiring prolonged hospitalisation and interference with oral feeding
  • 3. Presence of a gross congenital malformation incompatible with life
  • 4. Parent or Legally authorized representative (LAR) not providing written consent

研究者

发起方
Indian Council of Medical Research Hqrs

相似试验

已完成
3 期
ABDALA Clinical Study - Phase IIICOVID-19SARS-CoV2Disease PreventionCoronavirus InfectionsSARS VirusCoronaviridae InfectionsBetacoronavirus
RPCEC00000359Center for Genetic Engineering and Biotechnology (CIGB), in Havana.48,290
尚未招募
3 期
Clinical trial to compare the efficacy and safety between the combination of dorzolamide hydrochloride (2%) + brimonidine tartrate (0.2%) + timolol maleate (0.5%) and COMBIGAN® (combination of 0.2% brimonidine tartrate + 0.5% timolol maleate) in reducing ocular pressure in adult patients with primary open-angle glaucoma or high pressure in the eyesopen-angle glaucomaocular hypertensionglaucoma suspicionC11.525.381.407C11.525H40.1H40.0Primary open-angle glaucoma
RBR-3crsfjaboratório Daudt Oliveira Ltda.
进行中(未招募)
3 期
Phase III, multi-center, randomized, double-blind, placebo-controlled study for treatment of juvenile ankylosing spondylitis with AdalimumabM08.1juvenile ankylosing spondylitisJuvenile ankylosing spondylitis
DRKS00000071Asklepios Klinik Sankt Augustin32
进行中(未招募)
不适用
Phase III, multicentre, double-blind, randomised, placebo-controlled, study to assess the efficacy of V0337 SO 01A suspension 10ml 4 times a day during 7 days on 2 parallel groups of patients suffering from symptoms of gastro-oesophageal reflux disease (GORD)GORD-related symptomsMedDRA version: 9.1Level: LLTClassification code 10017885Term: Gastrooesophageal reflux disease
EUCTR2008-002562-60-FRPIERRE FABRE MEDICAMENT
进行中(未招募)
1 期
A study with a medicated nail lacquer for the treatment of toenail fungal infectiotoenail onychomycosisMedDRA version: 20.0 Level: PT Classification code 10030338 Term: Onychomycosis System Organ Class: 10021881 - Infections and infestations
EUCTR2016-003784-19-LVaboratorio Reig Jofre, SA360